|
| Press Releases |
|
|
| Monday, June 15, 2009 |
|
|
荷兰银行.摩根为亚洲投资者寻找在澳大利亚资源及矿产业中的投资机会 |
| 虽然,目前的金融风暴正为经济带来多方面的冲击,但对一些手头上有充足资金的投资者来说,这次金融风暴却带来了一个千载难逢的投资机遇.在澳大利亚,我们可以观察到有许多中国企业正在即极地寻找资源及矿产业中的投资机会.在金融危机未完全平复之下,中国的资金流入也受到很多澳大利亚企业的支持。 more info >> |
|
|
荷蘭銀行.摩根為亞洲投資者尋找在澳大利亞資源及礦產業中的投資機會 |
| 雖然,目前的金融風暴正為經濟帶來多方面的衝擊,但對一些手頭上有充足資金的投資者來說,這次金融風暴卻帶來了一個千載難逢的投資機遇.在澳大利亞,我們可以觀察到有許多中國企業正在即極地尋找資源及礦產業中的投資機會.在金融危機未完全平復之下,中國的資金流入也受到很多澳大利亞企業的支持。 more info >> |
|
|
ABN AMRO Morgans Helping Asian Investors to Look for Investment Opportunities in the Australia Resource Sector |
| While the down turn in the economy represents challenges for some, it is not the case for those cash rich investors who are looking for investment opportunities at a discounted price. It is evident that many Chinese companies are buying into Australia resource sector at an unprecedented rate recently. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
GIC Invests US$100M in Ascletis Pharma (1672. HK): Anchoring Long-Term Capital in China's Core Innovative Drug Assets
Feb 6, 2026 17:45 HKT/SGT
|
|
|
COSMOPlat Introduces Full-Stack AI to Hong Kong for Trillion-Dollar Industrial Digitalization
Feb 6, 2026 17:34: JST
|
|
|
GIC Private Limited initiated a stake in Ascletis Pharma (01672) by 64,128,000 shares at a price of HKD 12.18 per share
Feb 6, 2026 17:01 HKT/SGT
|
|
|
歌禮製藥-B（01672）獲新加坡政府投資公司首次入股 涉資約1億美元
Feb 6, 2026 16:56 HKT/SGT
|
|
|
歌礼制药-B（01672）获新加坡政府投资公司首次入股 涉资约1亿美元
Feb 6, 2026 16:50 HKT/SGT
|
|
|
COSMOPlat Introduces Full-Stack AI to Hong Kong for Trillion-Dollar Industrial Digitalization
Feb 6, 2026 16:34 HKT/SGT
|
|
|
トヨタ、役員人事を発表
Feb 6, 2026 16:00: JST
|
|
|
Distinct Healthcare Successfully Listed on HKEX, Bolstered by Premium Customer Base and All-Star Cornerstone Investors
Feb 6, 2026 15:55 HKT/SGT
|
|
|
Muyuan Foods Makes Hong Kong Debut Today: Strong Cornerstone Investor Backing Fuels Rapid Earnings Growth, Embarking on New Journey of Internationalization
Feb 6, 2026 15:40 HKT/SGT
|
|
|
Everest Medicines Announces China NMPA Approval of VELSIPITY(R) for Adults with Moderately to Severely Active Ulcerative Colitis
Feb 6, 2026 15:17: JST
|
|
|
牧原股份港股上市：全球生豬养殖龍頭 價值成長兼具
Feb 6, 2026 15:08 HKT/SGT
|
|
|
牧原股份港股上市：全球生猪养殖龙头 价值成长兼具
Feb 6, 2026 15:01 HKT/SGT
|
|
|
優異供應鏈賦能與國際化佈局雙輪驅動 綠茶開啟高質量成長新篇章
Feb 6, 2026 14:47 HKT/SGT
|
|
|
优异供应链赋能与国际化布局双轮驱动 绿茶开启高质量成长新篇章
Feb 6, 2026 14:33 HKT/SGT
|
|
|
Everest Medicines Announces China NMPA Approval of VELSIPITY(R) for Adults with Moderately to Severely Active Ulcerative Colitis
Feb 6, 2026 14:17 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
